News & Events |
 |
|
Just Released
French Physicians to Conduct 2000-Patient Study of CATANIA™ Coronary Stent
Learn more... |
|
| |
| News Archives |
October 14, 2009
CeloNova BioSciences' Embozene Microspheres receives approval.
Learn more... |
| |
October 6, 2009
Scientific Paper Supports Micro-Bland Embolization Technique for Liver Cancer with Embozene™ Microspheres
Learn more... |
| |
September 16, 2009
New Micro-Bland Embolization Technique with Embozene™ Microspheres to Be Presented at the International Medical Conference in Lisbon, Portugal
Learn more... |
| |
March 16, 2009
'New Class' of Coronary Stent Shows Sustained 12-Month Benefit in the Treatment of De Novo Coronary Lesions.
Learn more... |
| |
March 16, 2009
Frost and Sullivan Awards CeloNova BioSciences the 2009 North American Interventional Cardiology Product Innovation of the Year Award
Learn more... |
| |
December 16, 2008
CeloNova BioSciences is pleased to announce the FDA market clearance of Embozene™ Microspheres in the United States
Learn more... |
| |
December 16, 2008
CeloNova BioSciences receives FDA market approval for Embozene™ Color-Advanced microspheres embolization platform.
Learn more... |
| |
December 3, 2008
CeloNova BioSciences Comercializes the CATANIA™ Coronary Stent System with NanoThin Polyzene®-F in Europe and Middle East.
Learn more... |
| |
October 30, 2008
The CATANIA™ Coronary Stent System - a new class of stent - is the Latest News in the October 30, 2008 edition of Coronary Heart magazine.>
Learn more... |
| |
October 13, 2008
12-Month ATLANTA Trial Data Show Sustained Benefit of CATANIA™ Stent in Treatment of De Novo Coronary Lesions
Learn more... |
| |
October 8, 2008
CeloNova BioSciences to showcase the CE marked CATANIA™ Coronary Stent System featuring Nanothin Polyzene®-F at TCT Debut
Learn more... |
| |
October 1, 2008
Physician to Implant the CATANIA™ Coronary Stent System with Polyzene®-F to Treat Chronic Total Occlusion During “Live” Case at the Paris Cardiovascular Interventions Course (FRANCOPHONE) 2008
Learn more... |
| |
September 30, 2008
Bland Embolization for Liver Tumors with the Novel 40 Micron Embozene™ Microsphere
Industry Symposium: F. Orsi; Milan, Italy
Learn more...
|
| |
September 14, 2008
The Little Mermaid’s mysteries of medicine and destiny revealed.
Industry Symposium: Industry Symposium: T. Gordy; Newnan, United States of America
Learn more...
|
| |
July 15, 2008
The CATANIA™ Coronary Stent System - a new class of stent - is the Latest News in the July/August edition of Coronary Heart magazine.
Learn more... |
| |
July 11, 2008
International Meeting on Cardiovascular Interventions Breaks Free From Conventional BMS vs. DES Talk
Learn more... |
| |
June 20, 2008
Embozene™ Microspheres are the Featured Technology in Endovascular Today’s Special Issue on Embolization
Click here to read Embozene™ Color-Advanced Microspheres.
Click here to read 40-µm Tightly Calibrated Embozene™ Color-Advanced Microspheres. |
| |
April 30, 2008
CATANIA™ Stent System is Featured Technology in Cardiac Interventions Today
Learn more... |
| |
January 21, 2008
Super-Thin Drug-Free Coating 'Hides' Stent as it Unblocks Heart Arteries
Learn more... |
| |
January 20, 2008
CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA™ Coronary Stent System with NanoThin Polyzene®-F
Learn more... |
| |
January 20, 2008
CeloNova BioSciences Announces Positive Results from European Study of Embozene™ Microspheres for Treatment of Uterine Fibroids
Learn more... |
| |
November 1, 2007
CeloNova BioSciences, Inc is a proud sponsor of the 2008 International Symposium on Endovascular Therapy (ISET), January 20 - 24.
Learn more |
| |
September 20, 2007
CeloNova BioSciences, Inc. invites you to visit Booth No. 13 at GISE in Genoa, Italy
Learn more |
| |
September 13, 2007
CeloNova BioSciences Celebrates A Successful Annual Congress by CIRSE
Learn more
|
| |
September 7, 2007
CeloNova BioSciences, Inc is proud to be a sponsor of CIRSE 2007 in Athens, Greece September 8 - 12.
Learn more |
| |
